Open original FDA record ↗Recall record
- FDA identifier
- Z-0265-05
- Company in FDA record
- Beckman Coulter Inc
- FDA classification date
- Nov 30, 2004
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
A rare condition of the Access 2 Immunoassay Systems software versions 2.0, 2.1 and 2.2 could present a risk of an erroneous confirmatory result under a specific set of circumstances. The Chlamydia Blocking results may be affected. The instrument will erroneously perform the blocking calculation on the affected test by using the mean of the diluted and neat results.
Source facts
- Action
- Product Corrective Action (PCA) letter that informs customers (who ordered Access Chlamydia reagent in the past 24 months and have an Access 2 Immunoassay System) of this potential issue sent via US mail on November 8, 2004. The letter instructs customers to use unique Sample IDs for all samples assayed on the system - including those which have been manipulated offline prior to assay. A Technical Information Update will be issued to inform all support personnel of this issue.
- Initiated
- 2004-11-08
- Root cause
- Other
- Terminated
- 2012-08-13
- Distribution
- Nationwide and Canada
- Recall number
- Z-0265-05
- Recall status
- Terminated
- CDRH record ID
- 35834
- FDA classified
- 2004-11-30
- Recall event number
- 30421